Chiral kinetics and dynamics of ketorolac

Journal of Clinical Pharmacology

Volumn 36, Issue 6, 1996, Pages 521-539

  Mroszczak, Edward ^d   Combs, Daniel ^a   Chaplin, Melvin ^d   Tsina, Irene ^d   Tarnowski, Thomas ^b   Rocha, Cynthia ^b   Tam, Yuen ^b   Boyd, Aileen ^c   Young, John ^d   Depass, Linval ^b  

^a GENENTECH INC   (United States)

^b ROCHE BIOSCIENCE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARRAGEENAN; KETOROLAC; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLBUTAZONE; PHENYLQUINONE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; AREA UNDER THE CURVE; CLINICAL ARTICLE; CONFERENCE PAPER; DOSE TIME EFFECT RELATION; DRUG MECHANISM; DRUG METABOLISM; DRUG STRUCTURE; ENANTIOMER; HUMAN; HUMAN EXPERIMENT; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PAIN; POSTOPERATIVE PAIN; PROSTAGLANDIN SYNTHESIS INHIBITION; RACEMIC MIXTURE; RAT; RECTAL DRUG ADMINISTRATION;

EID: 8944223030     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1996.tb05042.x     Document Type: Conference Paper

References (23)

1. Hillier K: Drugs Future 1981;6:669-670.
2. Muchowski J, Unger S, Ackrell J, Cheung P, Cooper GF, Cook J, et al: Synthesis and anti-inflammatory and analgesic activity of 5-aroyl-1,2-dihydro- 3H-pyrrolo [1,2a]pyrrole-1-carboxylic acids and related compounds. J Med Chem 1985;28:1037-1049.
3. Rooks W, Tomolonis A, Maloney P, Wallach M, Schuler M: The analgesic and anti-inflammatory profile of (±)-5-benzoyl-1,2- dihydro-3H-pyrrolo [1,2a]pyrrole-1-carboxylic acid (RS-37619). Agents Actions 1982;12:684-690.
4. Rooks W, Maloney P, Shott L, Schuler M, Sevelius H, Strosberg AM, et al: The analgesic and anti-inflammatory profile of ketorolac and its tromethamine salt. Drugs Exp Clin Res 1985;11:479-492.
5. Bloomfield S, Mitchell J, Cissell G, Barden T: RS-37619 and aspirin analgesia for post-partum uterine cramps (abstract). Clin Pharmacol Ther 1984;35:228.
6. Yee J, Brown C, Sevelius H, Wild V: The analgesic efficacy of (±)-5-benzoyl-1,2-dihydro-3H-pyrrolo [1,2a]pyrrole-1-carboxylic acid, tromethamine salt in post-operative pain (abstract). Clin Pharmacol Ther 1984;35:284.
7. Yee J, Allison C, Koshiver J, Brown C: Analgesia from intramuscular ketorolac tromethamine compared to morphine sulfate in severe pain following major surgery. Pharmacotherapy 1980;6:253-261.
8. Mroszczak E, Lee F, Combs D, Sarnquist F, Huang B, Wu A, et al: Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans. Drug Metab Dispos 1987;15:618-626.
9. Jamali F: Pharmacokinetics of enantiomers of chiral non-steroidal anti-inflammatory drugs. Eur J Drug Metab Pharmacokinet 1988;13:1-9.
10. Tsina I, Chu F, Kaloostian M, Pettibone M, Wu A: HPLC method for the determination of ketorolac in human plasma. J Liquid Chromatogr 1996;19:957-967.
11. Tsina I, Tam YL, Boyd A, Rocha C, Tarnowski T: An indirect (derivatization) and direct HPLC method for the determination of the enantiomers of ketorolac in plasma. J Pharm Biomed Anal (in press).
12. Gibaldi M, Perrier D: Pharmacokinetics. Second edition. New York: Marcel Dekker, 1982.
13. Kaplan S, Jack M, Colter S, Alexander K: Utilization of area under the curve to elucidate the disposition of an extensively biotransformed drug. J Pharmacokinet Biopharm 1973;1:201-216.
14. Hayball P, Holman J, Nation R, Massy-Westropp R, Hamon D: Marked enantioselective protein binding in humans of ketorolac in vitro: elucidation of enantiomer unbound fractions following facile synthesis and direct chiral HPLC resolution of tritium-labeled ketorolac. Chirality 1994;6:642-648.
15. Hutt A, Caldwell J: The metabolic chiral inversion of 2-arylpropionic acids: a novel route with pharmacological consequences. J Pharm Pharmacol 1983;35:693-704.
16. Baillie T, Adams W, Kaiser D, Olanoff LS, Halstead GW, Harpootlian H, van Giessen GJ: Mechanistic studies of the metabolic chiral inversion of (R)- ibuprofen in humans. J Pharmacol Exp Ther 1989;249:517-523.
17. Nakamura Y, Yamaguchi T, Takahashi S, Hashimoto S, Iwatani K, Nakagawa Y: Optical isomerization mechanism of R(-)-hydrotropic acid derivatives (abstract). J Pharmacobio Dynamics 1981;4:S-1.
18. Wechter W, Lougheed D, Reischer R, van Giessen GJ, Kaiser DG: Enzymatic inversion at saturated carbon: nature and mechanism of the inversion of R(-)p-iso-butylhydratropic acid. Biochem Biophys Res Commun 1974;61:833-837.
19. Caldwell J, Marsh M: Interrelationships between xenobiotic mechanism and lipid biosynthesis. Biochem Pharmacol 1983;32:1667-1672.
20. Grubb N, Hall S, Brater D: The role of ketorolac adenylate in the chiral inversion of ketorolac (abstract). J Clin Pharmacol 1995;35:939.
21. Berg P: The chemical synthesis of amino acyl adenylates. J Biol Chem 1958;233:608-611.
22. Menzel S, Waibel R, Brune K, Geisslinger G: Is the formation of R-ibuprofenyl-adenylate the first stereoseloctive step of chiral inversion? Biochem Pharmacol 1994;48:1056-1058.
23. Fears R, Baggaley K, Alexander R, Morgan B, Hindley RM: The participation of ethyl 4-benzyloxybenzoate (BRL 10894) and other aryl-substituted acids in the glycerolipid mechanism. J Lipid Res 1978;19:3-11.